Providers underestimate the intensity of patients’ pain during IUD insertion, and often misidentify the moment at which maximum pain occurs, according to a randomized trial of 200 women. Midlevel providers are slightly better at estimating pain intensity.
Providers underestimate the intensity of patients’ pain during IUD insertion, and often misidentify the moment at which maximum pain occurs, according to a randomized trial of 200 women. Midlevel providers are slightly better at estimating pain intensity.
The study, presented at the American Congress of Obstetricians and Gynecologists’ Annual Clinical Meeting, was a secondary analysis of a randomized, placebo-controlled trial that investigated the use of intracervical lidocane gel as an analgesic during IUD insertion (Cu T380A or LNG IUS). Women were between the ages of 18 and 45 with a mean average age of 27.6. None of the women had a recent pregnancy, and 30% were nulliparous.
Using a 100 mm visual analog scale (VAS), women marked the level of pain they felt at four points: tenaculum placement, uterine sounding, IUD insertion, and speculum removal. On an identical scale, providers marked the point during insertion that they perceived to be most painful, along with the perceived level of pain.
Participants mean maximum pain score was 63.8 (standard deviation [SD] 27) compared with the mean maximum pain score of 35.3 reported by the providers (SD 26), P<.001). Midlevel provider ratings were 6.6 points closer to the patient’s pain score than attending physicians (P=.04).
In both intensity of pain and the point of greatest pain, agreement between patient experience and provider perceptions showed “very poor agreement,” said lead author Karla Maguire, MD, MPH, of the Miller School of Medicine in Miami, Fla. (kappa 0.16, confidence interval [CI] 0.07, 0.25). While midlevel providers, including advanced practice nurses and physicians assistants, are slightly better at estimating patients’ pain, they were equivalent to primary providers in estimating the moment of greatest pain. Only 19% of all providers were within 10 mm of perceived pain rates indicated by patients.
Maguire said that while IUDs have low failure rates and high continuation rates, pain may be a barrier to IUD use. “Underestimations of pain [by providers] can lead to pain mismanagement,” said Maguire. She said it could also lead to lack of potentially beneficial research.
Recap on reproductive rights with David Hackney, MD, MS
December 20th 2022In this episode of Pap Talk, we spoke with David Hackney, MD, MS, maternal-fetal medicine physician at Case Western Reserve University and chair of ACOG's Ohio chapter for a full recap of where restrictions on reproductive rights have been and where they're going.
Listen
Buprenorphine use in pregnancy linked to decreased fetal breathing movements
May 18th 2024According to a poster presented at ACOG 2024, use of the synthetic opioid buprenorphine depressed fetal breathing in biophysical profile assessments, but had no significant impact on other factors like amniotic fluid index or fetal tone.
Read More
In this episode of Pap Talk, Gloria Bachmann, MD, MSc, breaks down what it means to be a health care provider for incarcerated individuals, and explores the specific challenges women and their providers face during and after incarceration. Joined by sexual health expert Michael Krychman, MD, Bachmann also discusses trauma-informed care and how providers can get informed.
Listen
Laparoscopic RFA linked to enhanced pregnancy outcomes in uterine fibroid patients
May 18th 2024A recent study presented at the 2024 ACOG Clinical and Scientific Meeting reveals that laparoscopic radiofrequency ablation significantly improves pregnancy outcomes for women with uterine leiomyomas.
Read More
Identifying gaps in syphilis treatment and prenatal care among pregnant individuals
May 17th 2024Preventing congenital syphilis comes down to quick diagnosis and treatment of the infection in pregnancy, and the number of missed opportunities to do so in the United States continues to grow.
Read More